Lisheng Pharmaceutical Gets Green Light to Market Indapamide Tablets
Lisheng Pharmaceutical Gets Green Light to Market Indapamide Tablets
利生药品获得上市印度噻嗪片的许可证。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册